BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36283344)

  • 61. Acute Myocardial Infarction after Intravenous Thrombolysis for Acute Ischemic Stroke: Case Series and Systematic Review.
    Marto JP; Kauppila LA; Jorge C; Faustino P; Sargento-Freitas J; Pereira L; Galego S; Dias R; Castro P; Pinho-E-Melo T; Fonseca AC
    J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106244. PubMed ID: 34915306
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA.
    Zhao J; Dong L; Hui S; Lu F; Xie Y; Chang Y; Yang B
    Clin Appl Thromb Hemost; 2023; 29():10760296231198042. PubMed ID: 37670481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduction in the Ratio of Low-density Lipoprotein Cholesterol to Highdensity Lipoprotein Cholesterol is Associated with Increased Risks of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke.
    Wang Y; Wei C; Song Q; Liu J; Cheng Y; Li Y; Wu B; Liu M
    Curr Neurovasc Res; 2019; 16(3):266-272. PubMed ID: 31258087
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The risk factors of early hemorrhage after emergency intravenous thrombolysis in patients with acute ischemic stroke.
    Zhang X; Yu Y; Jiang L; Chen T; Sang Y; Wang Y; Ren Y; Mao G; Gu Y; Shen H; Lu J
    Ann Palliat Med; 2021 May; 10(5):5706-5713. PubMed ID: 34107714
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.
    Tanaka K; Matsumoto S; Furuta K; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Does dementia increase risk of thrombolysis?: a case-control study.
    Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
    Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determinants for a low dose of alteplase and its relationship to a lower intracerebral bleeding risk in acute ischemic stroke.
    Chen J; Li H; Lei H; Fang S; Yuan Q; Chen Y; Chen D; Chen R; Zhang Y; Wei J; Chen G; Chen Z; Liu N; Du HW
    Int J Med Sci; 2022; 19(12):1762-1769. PubMed ID: 36313231
    [No Abstract]   [Full Text] [Related]  

  • 72. Utilization rates of intravenous thrombolysis for acute ischemic stroke in Asian countries:: A systematic review and meta-analysis.
    Gajurel BP; Nepal G; Jaiswal V; Ang SP; Nain P; Shama N; Ruchika FNU; Bohara S; Kharel S; Yadav JK; Medina JRT; Shrestha AB
    Medicine (Baltimore); 2023 Oct; 102(42):e35560. PubMed ID: 37861564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator.
    Liu SY; Cao WF; Wu LF; Xiang ZB; Liu SM; Liu HY; Pan Y; Nie F; Wu XM; Xie XF
    Medicine (Baltimore); 2018 Dec; 97(49):e13216. PubMed ID: 30544380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
    Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
    Wang W; Li M; Chen Q; Wang J
    Mol Neurobiol; 2015 Dec; 52(3):1572-1579. PubMed ID: 25367883
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience.
    Cui Y; Zhou ZH; Hou XW; Chen HS
    Cerebrovasc Dis Extra; 2020; 10(3):148-158. PubMed ID: 33091902
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of Risk Factors Increased Hemorrhagic Transformation after Acute Ischemic Stroke.
    Ge WQ; Chen J; Pan H; Chen F; Zhou CY
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3587-3590. PubMed ID: 30217636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke.
    Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B
    J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stroke Thrombolysis in Patients Taking Ticagrelor -Two Successful Cases and a Review of the Literature.
    Landzberg DR; English S; Frankel M; Navalkele D
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105520. PubMed ID: 33310594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.